Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04255524
Other study ID # OCTAPPA
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 1, 2020
Est. completion date December 31, 2030

Study information

Verified date January 2020
Source The First Affiliated Hospital with Nanjing Medical University
Contact Zizong Hu, PhD, MD
Phone +8615195960100
Email huzizhong@njum.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Myopia is a global healthy concern, especially the high myopia and pathological myopia among Asian populations. However, its mechanism still remains largely unclear. Recent findings suggested choroidal changes might be related to the development of myopia. This study is to useOCT angiography (OCT-A) to investigate parapapillary choroidal microvasculature change in myopic eyes, and try to find the cause-and-effect relationship between choroidal change and the development of myopia.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date December 31, 2030
Est. primary completion date December 31, 2030
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

1. Spherical equivalent measurement can be included in above 4 groups

2. Willing to be followed up in the future 10 years

Exclusion Criteria:

1. Deny to sign the patient consent, or deny to be followed

2. Evidence of cardiac, or diabetic, or CNS disease.

3. Clinically diagnosed with retinal or choroidal disease

4. Glucoma

5. Cataract or corneal disease that influence the quality of fundus OCTA image

Study Design


Intervention

Device:
Optic coherence tomography angiography (OCTA)
Using non-invasive, repeatable, mature device OCTA to obtain choroidal angio-map

Locations

Country Name City State
China First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
The First Affiliated Hospital with Nanjing Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Parapapillary choroidal microvasculature void (MvV) area area of parapapillary choroidal microvasculature void on OCTA images changes of MvV area from at 10 years
Primary Parapapillary choroidal microvasculature void (MvV) area area of parapapillary choroidal microvasculature void on OCTA images difference of MvV area in each group at baseline
Primary Parapapillary choroidal microvasculature void (MvV) area area of parapapillary choroidal microvasculature void on OCTA images changes of MvV area at 1 years
Primary Parapapillary choroidal microvasculature void (MvV) area area of parapapillary choroidal microvasculature void on OCTA images changes of MvV area at 3 years
Primary Parapapillary choroidal microvasculature void (MvV) area area of parapapillary choroidal microvasculature void on OCTA images changes of MvV area at 5 years
Secondary MvV number number of choroidal MvV with certain size baseline
Secondary Correlation coefficient between choroidal MvV and refractive power Correlation coefficient between choroidal MvV and refractive power baseline
Secondary Correlation coefficient between choroidal MvV and PPA area Correlation coefficient between choroidal MvV and parapapillary atrophy beta area baseline
Secondary Correlation coefficient between choroidal MvV and choroid thickness Correlation coefficient between choroidal MvV and choroid thickness baseline
Secondary Correlation coefficient between choroidal MvV and RNFL thickness Correlation coefficient between choroidal MvV and RNFL thickness baseline
Secondary Correlation coefficient between choroidal MvV and Axial length Correlation coefficient between choroidal MvV and Axial length baseline
Secondary Correlation coefficient between choroidal MvV and retinal parapapillary perfusion Correlation coefficient between choroidal MvV and retinal parapapillary perfusion on OCTA images. baseline
Secondary Correlation coefficient between choroidal MvV and Macular perfusion Correlation coefficient between choroidal MvV and Macular perfusion on OCTA images, Retinal parapapillary perfusion with OCTA. baseline
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05919654 - Clinical Evaluation of MyoCare in Europe (CEME) N/A
Recruiting NCT03402100 - Eye Drops Study for Myopia Control in Schoolchildren N/A
Recruiting NCT03865160 - Low-dose Atropine for Myopia Control in Children Phase 2/Phase 3
Recruiting NCT06088225 - Myopia Preventing With Distance-image Screen N/A
Not yet recruiting NCT06085430 - Kubota Glass Parameter Refinement Study N/A
Not yet recruiting NCT06405711 - To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia N/A
Recruiting NCT05881655 - Slow Myopia Progression With Different Irradiance Light N/A
Recruiting NCT05761379 - Clinical Study of Light Therapy to Control Myopia Progression in Children N/A
Not yet recruiting NCT05760911 - Myopia Prevention Through Monitoring and Motivating Outdoor Activities With Smartwatches N/A
Recruiting NCT04722874 - Repeated Low-Level Red-Light Therapy and Orthokeratology in Fast-progressing Myopia Control N/A
Not yet recruiting NCT06221592 - Differences and Wearing Safety and Comfort of New Defocus Incorporated Multiple Segments Spectacle Lenses N/A
Completed NCT04806763 - Myopia Control With Orthokeratology Contact Lenses in Spain N/A
Completed NCT04806698 - Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia N/A
Completed NCT04806711 - Eleven Years of Menicon Z Night Contact Lens Wear in Reducing Myopia Progression in Children N/A
Recruiting NCT05894382 - Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control N/A
Completed NCT05683535 - Adverse Events Related to Low Dose Atropine
Completed NCT05300321 - DIMS-myopia Progression ADN Axial Length Growth N/A
Withdrawn NCT03519490 - Can Distance Center and Near Center Multifocal Contact Lenses Control Myopia Progression in Children? N/A
Completed NCT05372991 - Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop Phase 1/Phase 2
Active, not recruiting NCT05373693 - Myopia-control Efficacy by Peripheral Defocus Lens (PDL) N/A